World Market for Prescription Generic Drugs, 6th Edition
Pages: 250
Publisher: Kalorama Information
Date Published: April 2008
Format: PDF
Price: $3995
Overview
Generics, so long the force that has shaken up the branded pharmaceutical industry, is now facing its own challenges as an industry. While growth indications are strong, there are challenges for generic companies. In the next two years, consolidation will most likely rise; the sector is expected to be rocked by increased competition from companies in Eastern Europe, India and China, as well as brand name companies seeking to protect their franchises by moving into generics.
Kalorama Information’s World Market for Prescription Generic Drugs, 6th Edition is your guide to this formidable and important participant in the complex world of healthcare. Included are market size and forecast revnues for:
This report is the result of primary research and secondary research. Interviews with experts in the generic industry form the basis of this report. Research was conducted from available company reports, trade publications and medical and government databases. Interviews with experts are the source of models.
For each drug segment, the report provides:
- Estimated Generic Market Size
- Forecast to 2012
- Recent ANDA Approvals
- World and US Market Share
- Company Profiles
Knowledge of the issues that face the generics industry is essential to understanding the market. The report discusses the following trends:
- Legislative Issues
- Big Pharma Tactics
- Authorized Generics
- Generic Biologics
- Medicaid Generic Drug Reimbursement
- The Elderly
- Confusion in Generic Names
- Broadening Generic Horizons
- International Generic Drug Issues
- Indian Drug Makers
- Industry Consolidation
- New Generic Giants
- Patent Issues
- Generic Companies Increasingly Aggressive
- Patent Reform
- Generic Growth
- Generic Statins
- Cost
- Generics Improve Compliance
- Generic Drug Sampling
Marketing executives, business development managers and brand and generic pharmaceutical companies, consultants and investors are among those who will benefit from this report.
Table of Contents
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO:INTRODUCTION
- Development and Approval Process
CHAPTER THREE: ALLERGY AND RESPIRATORY DRUGS
- Asthma, Bronchodilators and Corticosteroids
- Inhaled Corticosteroids
- Antiasthmatic Agents
- Bronchodilating Agents
- Antihistamines, Decongestants, and Cough Preparations
- Antihistamines
- Decongestants
- Cough Preparations
- The World Market
- The U.S. vs World Market
CHAPTER FOUR: ANALGESICS, NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, AND ANTIRHEUMATIC DRUGS
- Product Categories
- Analgesics
- Nonsteroidal Anti-inflammatory Drugs
- Antirheumatics
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
CHAPTER FIVE: ANESTHESIA DRUGS
CHAPTER SIX: ANTI-INFECTIVES
CHAPTER SEVEN: CANCER DRUGS
CHAPTER EIGHT: CARDIOVASCULAR DRUGS
- Positive Inotropic Agents
- Antiadrenergics
- Beta-Adrenergic Blocking Agents
- Vasodilators
- Calcium Channel Blockers
- Angiotensin-Converting Enzyme Inhibitors
- Antiarrhythmics
- Antihyperlipidemic Agents
- Anticoagulants
- Diuretics
CHAPTER NINE: CENTRAL NERVOUS SYSTEM AND PSYCHOTHERAPEUTIC DRUGS
- Product Categories
- Antidepressants, Stimulants, and Antipsychotics
- Antidepressants
- Stimulants
- Antipsychotics
- Anticonvulsants, Antispasmodics, and Muscle Relaxants
- Anticonvulsants
- Antispasmodics
- Muscle Relaxants
- Parkinson’s Disease, Myasthenia Gravis, and Multiple Sclerosis
- Parkinson’s Disease
- Myasthenia Gravis
- Multiple Sclerosis
- Sedatives, Hypnotics, and Antianxiety Drugs
- Product News
- Market Size and Forecast
- The World Market
- The U.S. vs World Market
- Competitive Analysis
CHAPTER TEN: GASTROINTESTINAL DRUGS
CHAPTER ELEVEN: HORMONAL DRUGS
CHAPTER TWELVE: OPHTHALMIC DRUGS
- Ophthalmic Anti-Infectives
- Ophthalmic Anti-Inflammatories and Mast Cell Inhibitors
- Glaucoma Agents
CHAPTER THIRTEEN: WORLD MARKET SUMMARY
CHAPTER FOURTEEN: ISSUES AND TRENDS
CHAPTER FIFTEEN: COMPANY PROFILES
APPENDIX: COMPANY DIRECTORY
